Beta Bionics (BBNX) Director Sean Carney Receives RSU Award

What Happened
Sean Carney, a director of Beta Bionics (BBNX), was granted 16,965 restricted stock units (RSUs) on 2026-05-21. The Form 4 reports the acquisition price as $0.00, so the reported acquisition value is $0 — this reflects an equity award rather than a purchase or sale of shares.

Key Details

• Transaction date: 2026-05-21. Form 4 filed: 2026-05-26.
• Transaction type/code: Award (A) — restricted stock unit grant.
• Shares granted: 16,965 RSUs; reported price per share: $0.00; reported total value: $0.
• Footnote: F1 — represents RSU award granted under the Issuer's 2025 Equity Incentive Plan.
• Shares owned after transaction: not specified in the provided filing.
• Timeliness: The Form 4 was filed five days after the transaction date; this exceeds the standard two-business-day SEC filing window for insiders and thus appears late.

Context
RSU grants typically vest over time and are subject to plan terms and restrictions; they do not represent an immediate open-market purchase or sale. An award reported at $0 on Form 4 is standard for grants and does not by itself indicate buy/sell sentiment. No immediate sale or tax-withholding detail is shown in this filing.